Therefore, this study was performed to examine the following two hypotheses: (1) an ARB could decrease urinary excretions of albumin and AGT in patients with metabolic syndrome; and (2) urinary AGT excretion could be a prognostic marker of the albuminuria reduction effects of ARB in patients with metabolic syndrome. This evidence concerns the gene AGT and metabolic syndrome.